Related references
Note: Only part of the references are listed.Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population
R. Brigg Turner et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis
Vineet Goti et al.
THERAPEUTIC DRUG MONITORING (2018)
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity
Natalie A. Finch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia
R. Chavada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias
Manjunath P. Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion
M. F. Waineo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Innovative approaches to optimizing the delivery of vancomycin in individual patients
Manjunath P. Pai et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
Michael N. Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vancomycin Monitoring in Children Using Bayesian Estimation
Jennifer Le et al.
THERAPEUTIC DRUG MONITORING (2014)
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Natasha E. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A Stewardship Program's Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis
Kristen M. Gawronski et al.
CLINICAL THERAPEUTICS (2013)
Evaluation of Once-Daily Vancomycin against Methicillin-Resistant Staphylococcus aureus in a Hollow-Fiber Infection Model
Anthony M. Nicasio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
Jack Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia
Yosuke Suzuki et al.
CHEMOTHERAPY (2012)
Vancomycin: We Can't Get There from Here
Nimish Patel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations
A. H. Thomson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy
Paul R. Ingram et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies
DS Buelga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study
M Wysocki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
